Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Bio NC

Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering

December 7, 2018

4 min read

Drug Development

Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial

November 19, 2018

4 min read

Bio NC

Tenax Therapeutics to Present at Upcoming Investor Conferences

September 20, 2018

3 min read

Bio NC

Tenax Therapeutics Announces New Clinical Study Publication Results Indicate Levosimendan Offers Renal Protective Benefits to Heart Failure Patients

August 28, 2018

4 min read

Drug Development

Tenax Therapeutics Announces Appointment of Anthony A. DiTonno as CEO

June 5, 2018

4 min read

Drug Development

Tenax Therapeutics Announces Study Design for Phase 2 Trial of Levosimendan in PH-HFpEF Patients

June 1, 2018

3 min read

Bio NC

Tenax Therapeutics Announces Results of Pre-IND Meeting with FDA for Phase 2 Study of Levosimendan in PH-HFpEF Patients

April 4, 2018

3 min read

Bio NC

Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

March 14, 2018

3 min read

Drug Development

Tenax Therapeutics Announces New Scientific Publication of Preclinical Data Provides Additional Evidence of Levosimendan Treatment Effects in Pulmonary Hypertension

March 1, 2018

4 min read

Business

World-Recognized Experts Join Tenax Therapeutics’ Scientific Advisory Board to Guide New Phase II Study

February 6, 2018

7 min read

JOBS